DeregulatedMIR335that targetsMAPK1is implicated in poor outcome of paediatric acute lymphoblastic leukaemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DeregulatedMIR335that targetsMAPK1is implicated in poor outcome of paediatric acute lymphoblastic leukaemia
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 163, Issue 1, Pages 93-103
Publisher
Wiley
Online
2013-07-26
DOI
10.1111/bjh.12489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimal Residual Disease–Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 Study
- (2012) Allen Eng Juh Yeoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
- (2012) Viswam S. Nair et al. JNCI-Journal of the National Cancer Institute
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)
- (2012) Jaqueline C. de Oliveira et al. PEDIATRIC BLOOD & CANCER
- Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer
- (2012) Zhi Yan et al. PLoS One
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
- (2011) L. E. Hogan et al. BLOOD
- MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
- (2011) K. J. Png et al. GENES & DEVELOPMENT
- MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia
- (2011) D. Schotte et al. HAEMATOLOGICA
- A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL
- (2011) Bo-Wei Han et al. HUMAN MOLECULAR GENETICS
- Epigenetic regulation of miRNA genes in acute leukemia
- (2011) X Agirre et al. LEUKEMIA
- MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1
- (2011) Y Xu et al. ONCOGENE
- miR-335 Directly Targets Rb1 (pRb/p105) in a Proximal Connection to p53-Dependent Stress Response
- (2010) M. Scarola et al. CANCER RESEARCH
- BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia
- (2010) Nan Jiang et al. EXPERIMENTAL HEMATOLOGY
- Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
- (2010) D J P M Stumpel et al. LEUKEMIA
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia
- (2009) R. M. A. Linger et al. BLOOD
- miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
- (2009) A. Kotani et al. BLOOD
- New Tricks for Animal MicroRNAs: Targeting of Amino Acid Coding Regions at Conserved and Nonconserved Sites
- (2009) I. Rigoutsos CANCER RESEARCH
- Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic Leukemia
- (2009) Jose Roman-Gomez et al. JOURNAL OF CLINICAL ONCOLOGY
- MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM
- (2009) A A Rambal et al. LEUKEMIA
- MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia
- (2009) Hua Zhang et al. PLoS One
- MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
- (2008) Sung-Liang Yu et al. CANCER CELL
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started